Added to YB: 2025-11-05
Pitch date: 2025-10-31
HLN [neutral]
Haleon plc
+1.27%
current return
Author Info
No bio for this author
Company Info
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
Market Cap
GBP 31.5B
Pitch Price
GBP 3.54
Price Target
N/A
Dividend
1.92%
EV/EBITDA
14.73
P/E
21.21
EV/Sales
3.58
Sector
Pharmaceuticals
Category
N/A
Theodosian Capital | Stocks Update 31/10/2025 - HLN – Solid Q3 update
HLN (update): Solid Q3 w/ 3.4% organic revenue growth to £2.8bn, balanced price/volume mix improving from 9m. Reaffirms FY 3.5% growth guidance & HSD op profit growth. Quality cash-generative wellness brands enable deleveraging/M&A optionality. 17.6x 2026 P/E vs peers like Colgate 19.7x, 2.2% yield.
Read full article (1 min)